Tuesday, December 29, 2020

Can pregnant women receive the Covid-19 vaccine?

Clinical trials for the Pfizer BioNTech Vaccine did not include either pregnant or lactating women, and the company has said available data is so far "insufficient" to determine any risks to pregnancy posed by the vaccine.

In the UK, this absence of data has led regulators to exclude pregnant and breastfeeding women from vaccination programme. In the US, the decision has been left up to these women themselves.

Here's why the two countries are split, and what that means for pregnant women.

So far, it doesn't say much at all.

"There were no data, period," said Dr Ruth Faden, a bioethicist at Johns Hopkins University, who specialises in the rights and health of pregnant women. There is no suggestion that the jab is especially risky for pregnant and lactating women, there just isn't yet enough information to say.

Pfizer has said it followed the guidance of the US Food and Drug Administration in leaving out pregnant and breastfeeding women from its clinical trials. These women will not be included in clinical trials until the company completes so-called Dart studies (developmental and reproductive toxicity), often conducted in animals.

Experts say this is customary.

"In non-pandemic times, if you are talking about a brand new vaccine, most reasonable people who are committed to advancing the interests of pregnant women and their offspring would still say we should not involve pregnant women" in early clinical trials, Dr Faden said. "You can't put them in right from the beginning".

In bioethics, pregnant women are described as "a complex population", Dr Faden said. "Nowhere else do you have two entities at one time, both of whom are objects of moral concern."

"And by and large, no one cares more about the well-being of the offspring than the pregnant woman. The first question you usually get is 'will this be safe for my baby?'" she said.

But the decision to leave out pregnant women from clinical trials is more complicated in the midst of a pandemic.

"We're in a tough place," said Dr Emily Stinnett Miller, an obstetrician at Northwestern University and a member of the Covid-19 task force of the Society for Maternal and Fetal Medicine. "They're having to make critical decisions quickly, and there are pros and cons to inclusion and exclusion."

A serious con - a lack of data - is evident now. "We don't really have the data to make these clinical decisions that we need to make," Dr Miller said.

Faced with the same lack of data, the UK and US are split in their policy response.

"When you have no data that speaks specifically to the question, then the next question is to step back and say 'OK, what otherwise do we know?'" Dr Faden said.

The UK has taken the more cautious path. On its website, Public Health England said that while the evidence "raises no concerns for safety in pregnancy", the agency "wants to see more non-clinical data" before finalising its advice for pregnancy.

"As specific clinical trials of Covid-19 vaccines in pregnant women have not yet been carried out, there isn't sufficient evidence to recommend the routine use of Covid-19 vaccines to pregnant or breastfeeding women," said Dr Edward Morris, president of the Royal College of Obstetricians and Gynaecologists (RCOG), in a statement.

Experts in the US went another way, leaving the the decision of vaccination to pregnant and breastfeeding women.

"The experts came to a consensus view that scientific plausibility of harm just wasn't there," Dr Faden said. But, she cautioned, "that doesn't mean zero".

The Covid vaccine trials may have happened at breakneck speed, but they haven't skipped any steps, regulators in the US and UK have said, and approval is only given when a vaccine is both safe and effective.

In both countries, pregnant and lactating women will have to wait for more information before getting a clearer recommendation on the vaccine.

Preliminary results from Pfizer's developmental and reproductive toxicity studies are expected by the end of the year. Once these studies are complete, the company may expand its clinical trials to include pregnant women. There are also a handful of women who became pregnant while in the midst of the trial who will be monitored through their pregnancy.

The Royal College of Obstetricians and Gynaecologists has urged the UK government to fund research studies on the vaccine and its suitability for pregnant and breastfeeding women. And data will also be collected from pregnant and breastfeeding women in the US who elect to take the vaccine in the coming months. This will come first from the country's healthcare workers - among the first in the US to be eligible - some 330,000 of whom are estimated to be pregnant or breastfeeding.

"We'll have to keep our fingers crossed that this data...will allow an unambiguous, full-throated recommendation on pregnancy," Dr Faden said.

In the meantime, some pregnant and breastfeeding women say they will avoid the jab.

Joanna Sullivan, 35, who lives in southwest Ohio, is expecting her first baby in June. She does not plan to seek the vaccine until after she gives birth.  "I don't know about any kind of complications, and being my first one, being older, there's already higher risk there," she said. And while it would be "helpful" to see how other pregnant women respond, Mrs Sullivan said she will likely hold off. In Gloucestershire, England, Amy Collender, 34, said she might consider the jab while breastfeeding, but only now that her son is nearly two years old. "If I had a newborn baby, I might not," she said. And if she were still pregnant, she would likely choose to opt-out. And both women said that while they'd like more information, they would not volunteer to participate in a clinical trial themselves. "That's the thing, I understand why there weren't pregnant people doing the trial," Mrs Sullivan said. "Who wants to put their baby at risk?" But according to Dr Faden, successful inoculation against Covid-19 means that pregnant and breastfeeding must be included. "We cannot have an effective vaccine against this pandemic unless we have a vaccine that pregnant women can take, full stop," Dr Faden said.

Thursday, May 14, 2020

What is a novel coronavirus?


What is a novel coronavirus?

â€ĸCoronaviruses (CoV) are a large family of viruses that cause a wide range of illness from the common cold to more severe diseases

â€ĸi.e., Middle East Respiratory Syndrome [MERS] and Severe Acute Respiratory Syndrome [SARS]

â€ĸA novel coronavirus (nCoV) is a new strain that has not been previously identified in humans.

 â€ĸCoronaviruses (CoV) are a large family of viruses that cause a wide range of illness from the common cold to more severe diseases. They are often zoonotic.

â€ĸI.e., Middle East Respiratory Syndrome [MERS] and Severe Acute Respiratory Syndrome [SARS]

â€ĸSeveral known coronaviruses are circulating in animals that have not yet infected humans.

â€ĸOn 31 December 2019, the WHO China Country Office was informed of pneumonia cases of unknown cause in Wuhan City, Hubei Province of China.A novel coronavirus (COVID-19) was isolated and identifiedas the causative virus by Chinese authorities on 7 January.

Ref: WHO website

Wednesday, May 13, 2020

āĻ•āϰ⧋āύāĻž āĻ­āĻžāχāϰāĻžāϏ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻĨ⧇āϕ⧇ āĻŦāĻžāρāϚāϤ⧇ āφāĻ—āĻžāĻŽā§€ ā§§ āĻŦāĻ›āϰ⧇āϰ āϜāĻ¨ā§āϝ ⧍⧍ āϜāϰ⧁āϰ⧀ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻĻāĻŋāϞ⧇āύ āĻĄāĻžāσ āĻĻ⧇āĻŦā§€ āĻļ⧇āĻ āĻŋ

www.discoverworldwide.blogspot.comāĻ•āϰ⧋āύāĻž āĻ­āĻžāχāϰāĻžāϏ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻĨ⧇āϕ⧇ āĻŦāĻžāρāϚāϤ⧇ āφāĻ—āĻžāĻŽā§€ ā§§ āĻŦāĻ›āϰ⧇āϰ āϜāĻ¨ā§āϝ ⧍⧍ āϜāϰ⧁āϰ⧀ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻĻāĻŋāϞ⧇āύ āĻĄāĻžāσ āĻĻ⧇āĻŦā§€ āĻļ⧇āĻ āĻŋ.......

ā§§. āĻāĻ• āĻŦāĻ›āϰ⧇āϰ āϜāĻ¨ā§āϝ āĻŦāĻŋāĻĻ⧇āĻļ āĻ­ā§āϰāĻŽāĻŖ āĻ¸ā§āĻĨāĻ—āĻŋāϤāĨ¤
⧍. āφāĻ—āĻžāĻŽā§€ āĻāĻ• āĻŦāĻ›āϰ āĻŦāĻžāχāϰ⧇āϰ āĻ–āĻžāĻŦāĻžāϰ āĻ–āĻžāĻŦ⧇āύ āύāĻžāĨ¤
ā§Š. āĻŦāĻŋā§Ÿā§‡ āĻŦāĻž āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻ…āύ⧁āϰ⧂āĻĒ āĻ…āύ⧁āĻˇā§āĻ āĻžāύ⧇ āϝāĻžāĻŦ⧇āύ āύāĻžāĨ¤
ā§Ē. āĻ…āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ āĻ­ā§āϰāĻŽāĻŖ āĻ•āϰāĻŦ⧇āύ āύāĻžāĨ¤
ā§Ģ. āĻ•āĻŽāĻĒāĻ•ā§āώ⧇ āĻāĻ• āĻŦāĻ›āϰ āϕ⧋āύ⧋ āĻ­āĻŋāĻĄāĻŧ⧇āϰ āϜāĻžāϝāĻŧāĻ—āĻžāϝāĻŧ āϝāĻžāĻŦ⧇āύ āύāĻžāĨ¤
ā§Ŧ. āϏāĻžāĻŽāĻžāϜāĻŋāĻ• āĻĻā§‚āϰāĻ¤ā§āĻŦ⧇āϰ āύāĻŋāϝāĻŧāĻŽāĻžāĻŦāϞ⧀ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖāϰ⧂āĻĒ⧇ āĻ…āύ⧁āϏāϰāĻŖ āĻ•āϰ⧁āύāĨ¤
ā§­. āĻ•āĻžāĻļāĻŋ āĻĨ⧇āϕ⧇ āĻĻā§‚āϰ⧇ āĻĨāĻžāϕ⧁āύāĨ¤
ā§Ž. āĻŽā§āĻ–ā§‹āĻļāϟāĻŋ āĻŽā§āĻ–ā§‹āĻŽā§āĻ–āĻŋ āϰāĻžāϖ⧁āύāĨ¤
⧝. āĻŦāĻ°ā§āϤāĻŽāĻžāύ āĻāĻ• āϏāĻĒā§āϤāĻžāĻšā§‡ āϖ⧁āĻŦ āϏāĻžāĻŦāϧāĻžāύāϤāĻž āĻ…āĻŦāϞāĻŽā§āĻŦāύ āĻ•āϰ⧁āύāĨ¤
ā§§ā§Ļ. āφāĻĒāύāĻžāϰ āϚāĻžāϰāĻĒāĻžāĻļ⧇ āϕ⧋āύ⧋ āĻ—ā§‹āϞāĻŽāĻžāϞ āĻšāϤ⧇ āĻĻ⧇āĻŦ⧇āύ āύāĻžāĨ¤
ā§§ā§§. āĻāĻ–āύ āĻĨ⧇āϕ⧇ ā§Ŧ āĻŽāĻžāϏ āϏāĻŋāύ⧇āĻŽāĻž āĻšāϞ, āĻļāĻĒāĻŋāĻ‚ āĻŽāϞ, āĻ­āĻŋāĻĄāĻŧ⧇āϰ āĻŦāĻžāϜāĻžāϰ⧇ āϝāĻžāĻŦ⧇āύ āύāĻžāĨ¤ āϏāĻŽā§āĻ­āĻŦ āĻšāϞ⧇ āĻĒāĻžāĻ°ā§āĻ•, āĻĒāĻžāĻ°ā§āϟāĻŋ āχāĻ¤ā§āϝāĻžāĻĻāĻŋāĻ“ āĻāĻĄāĻŧāĻžāύ⧋ āωāϚāĻŋāϤāĨ¤
⧧⧍. āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻ•ā§āώāĻŽāϤāĻž āĻŦāĻžāĻĄāĻŧāĻžāύāĨ¤
ā§§ā§Š. āύāĻžāĻĒāĻŋāϤ⧇āϰ āĻĻā§‹āĻ•āĻžāύ⧇ āĻŦāĻž āĻŦāĻŋāωāϟāĻŋ āϏ⧇āϞ⧁āύ āĻĒāĻžāĻ°ā§āϞāĻžāϰ⧇ āĻĨāĻžāĻ•āĻžāĻ•āĻžāϞ⧀āύ āϖ⧁āĻŦ āϝāĻ¤ā§āύāĻļā§€āϞ āĻšāύāĨ¤
ā§§ā§Ē. āĻ…āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ āϏāĻ­āĻžāϗ⧁āϞāĻŋ āĻāĻĄāĻŧāĻŋāϝāĻŧ⧇ āϚāϞ⧁āύ, āϏāĻ°ā§āĻŦāĻĻāĻž āϏāĻžāĻŽāĻžāϜāĻŋāĻ• āĻĻā§‚āϰāĻ¤ā§āĻŦ⧇āϰ āĻ•āĻĨāĻž āĻŽāĻžāĻĨāĻžāϝāĻŧ āϰāĻžāϖ⧁āύāĨ¤
ā§§ā§Ģ. āĻ•āϰ⧋āύāĻžāϰ āĻšā§āĻŽāĻ•āĻŋ āϖ⧁āĻŦ āĻļāĻŋāĻ—āĻ—āĻŋāϰāχ āĻļ⧇āώ āĻšāĻšā§āϛ⧇ āύāĻžāĨ¤
ā§§ā§Ŧ. āφāĻĒāύāĻŋ āĻŦāĻžāχāϰ⧇ āĻŦ⧇āϰ⧋āύ⧋āϰ āϏāĻŽāϝāĻŧ āĻŦ⧇āĻ˛ā§āϟ, āϰāĻŋāĻ‚āϗ⧁āϞāĻŋ, āϘāĻĄāĻŧāĻŋ āĻĒāϰāĻŦ⧇āύ āύāĻžāĨ¤ āϘāĻĄāĻŧāĻŋāϰ āĻĻāϰāĻ•āĻžāϰ āύ⧇āχāĨ¤ āφāĻĒāύāĻžāϰ āĻŽā§‹āĻŦāĻžāχāϞ āϏāĻŽāϝāĻŧ āĻĒ⧇āϝāĻŧ⧇āϛ⧇āĨ¤
ā§§ā§­. āϕ⧋āύ⧋ āĻšāĻžāϤ⧇āϰ āϰ⧁āĻŽāĻžāϞ āύāĻž, āĻ¸ā§āϝāĻžāύāĻŋāϟāĻžāχāϜāĻžāϰ āύāĻŋāύāĨ¤
ā§§ā§Ž. āφāĻĒāύāĻžāϰ āϘāϰ⧇ āϜ⧁āϤ⧋ āφāύāĻŦ⧇āύ āύāĻžāĨ¤ āĻŦāĻžāχāϰ⧇ āϰ⧇āϖ⧇ āĻĻāĻŋāύāĨ¤
⧧⧝. āφāĻĒāύāĻžāϰ āĻšāĻžāϤ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āĻ•āϰ⧁āύāĨ¤
⧍ā§Ļ. āφāĻĒāύāĻŋ āϝāĻ–āύ āĻŽāύ⧇ āĻ•āϰ⧇āύ āφāĻĒāύāĻŋ āϏāĻ¨ā§āĻĻ⧇āĻšāϜāύāĻ• āϰ⧋āĻ—ā§€āϰ āĻ•āĻžāϛ⧇ āĻāϏ⧇āϛ⧇āύ āϤāĻ–āύ āĻĒ⧁āϰ⧋ āĻ—ā§‹āϏāϞ āĻ•āϰ⧁āύāĨ¤
⧍⧧. āϞāĻ•āĻĄāĻžāωāύ āĻŦāĻž āϞāĻ•āĻĄāĻžāωāύ āĻĒāϰāĻŦāĻ°ā§āϤ⧀ ā§Ŧ āĻŽāĻžāϏ āĻĨ⧇āϕ⧇ ⧧⧍ āĻŽāĻžāϏ āĻāχ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻ…āύ⧁āϏāϰāĻŖ āĻ•āϰ⧁āύāĨ¤
⧍⧍. āφāĻĒāύāĻžāϰ āĻĒāϰāĻŋāĻŦāĻžāϰ āĻ“ āĻŦāĻ¨ā§āϧ⧁āĻĻ⧇āϰ āϏāĻ™ā§āϗ⧇ āĻāϟāĻŋ āĻ­āĻžāĻ—āĻžāĻ­āĻžāĻ— āĻ•āϰ⧁āύāĨ¤

(āϏ⧂āĻ¤ā§āϰ.... āĻ•āĻžāϞ⧇āϰ āĻ•āĻŖā§āĻ )

Tuesday, March 31, 2020

āĻ•āϰ⧋āύāĻžāϰ āφāϤāĻ™ā§āĻ• āĻĨ⧇āϕ⧇ āĻ•āĻŋāĻ­āĻžāĻŦ⧇ āĻŦāĻžāρāϚāĻŦ ?

 āύāϤ⧁āύ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āĻŦāĻž āϕ⧋āĻ­āĻŋāĻĄ-⧧⧝ āĻŦāĻ°ā§āϤāĻŽāĻžāύ⧇ āϏāĻžāϰāĻž āĻŦāĻŋāĻļā§āĻŦ⧇ āĻāĻ•āϟāĻŋ āφāϤāĻ™ā§āϕ⧇āϰ āύāĻžāĻŽāĨ¤ āĻĒā§āϰāĻĨāĻŽ āĻ“ āĻĻā§āĻŦāĻŋāĻ¤ā§€ā§Ÿ āĻŦāĻŋāĻļā§āĻŦāϝ⧁āĻĻā§āϧ⧇āϰ āĻĒāϰ āĻāχ āĻĒā§āϰāĻĨāĻŽ āĻĒ⧃āĻĨāĻŋāĻŦā§€āϰ āĻ…āϏāĻ‚āĻ–ā§āϝ āĻĻ⧇āĻļ⧇āϰ āĻŽāĻžāύ⧁āώ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻŽā§ƒāĻ¤ā§āϝ⧁āϭ⧟ āϜāĻžāĻ—āĻŋā§Ÿā§‡ āϤ⧁āϞ⧇āϛ⧇ āϕ⧋āĻ­āĻŋāĻĄ-⧧⧝ āϰ⧋āĻ—āĨ¤ āĻāϰāχ āĻŽāĻ§ā§āϝ⧇ āĻ āϰ⧋āϗ⧇ āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻŽāĻžāύ⧁āώ⧇āϰ āϏāĻ‚āĻ–ā§āϝāĻž ⧍ āϞāĻžāĻ– ā§Žā§Ļ āĻšāĻžāϜāĻžāϰ āĻ›āĻžā§œāĻŋā§Ÿā§‡ āϗ⧇āϛ⧇āĨ¤ āĻŽā§ƒāϤ āĻŽāĻžāύ⧁āώ⧇āϰ āϏāĻ‚āĻ–ā§āϝāĻž āĻ›āĻžā§œāĻŋā§Ÿā§‡āϛ⧇ āϏāĻžā§œā§‡ ā§§ā§§ āĻšāĻžāϜāĻžāϰāĨ¤ āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇āĻ“ āĻāϏ⧇āϛ⧇ āĻ•āϰ⧋āύāĻžāϰ āĻĨāĻžāĻŦāĻžāĨ¤ āφāϰ āϤāĻžāϰ āĻšā§‡ā§Ÿā§‡āĻ“ āĻŦ⧇āĻļāĻŋ āĻāϏ⧇āϛ⧇ āφāϤāĻ™ā§āĻ•āĨ¤ āĻŽāύ⧇āϰ āĻāχ āφāϤāĻ™ā§āĻ• āϰ⧋āĻ—āϕ⧇ āϠ⧇āĻ•āĻžāύ⧋āχ āĻāĻ–āύ āĻ…āĻ¨ā§āϝāϤāĻŽ āϏāĻŽāĻ¸ā§āϝāĻž āĻšā§Ÿā§‡ āĻĻāĻžāρ⧜āĻŋā§Ÿā§‡āϛ⧇āĨ¤

āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇āϰ āĻ—ā§āϰāĻžāĻŽ āĻ“ āĻļāĻšāϰ āϏāĻŦ āϜāĻžā§ŸāĻ—āĻžāϰ āĻŽāĻžāύ⧁āώ⧇āϰ āϭ⧇āϤāϰ āĻāĻ•āϧāϰāύ⧇āϰ āϚāĻžāĻĒāĻž āφāϤāĻ™ā§āĻ• āĻ•āĻžāϜ āĻ•āϰāϛ⧇āĨ¤ āĻĒ⧃āĻĨāĻŋāĻŦā§€āϰ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āĻĻ⧇āĻļ⧇āϰ āϏāϰāĻ•āĻžāϰ, āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻžāύ āĻ“ āϜāύāĻ—āĻŖ āϝāĻ–āύ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇āϰ āϜāĻ¨ā§āϝ āĻāĻ•āϝ⧋āϗ⧇ āĻ•āĻžāϜ āĻ•āϰāϛ⧇, āϤāĻ–āύ āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āύāĻŋā§Ÿā§‡ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āϧāϰāύ⧇āϰ āĻŽāĻŋāĻĨā§āϝāĻž āϤāĻĨā§āϝāϏāĻŽā§ƒāĻĻā§āϧ āϗ⧁āϜāĻŦ āĻ›ā§œāĻžāύ⧋ āĻšāĻšā§āϛ⧇āĨ¤ āĻāϟāĻŋ āϏāĻžāĻŽāĻžāϜāĻŋāĻ•āĻ­āĻžāĻŦ⧇ āϭ⧟āĻ‚āĻ•āϰāĨ¤ āĻŦāĻ°ā§āϤāĻŽāĻžāύ⧇ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇āϰ āĻšā§‡ā§Ÿā§‡ āϗ⧁āϜāĻŦ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻ•āϰāĻž āĻŽā§āĻ–ā§āϝ āĻ•āĻžāϜ āĻšā§Ÿā§‡ āĻĻāĻžāρ⧜āĻŋā§Ÿā§‡āϛ⧇āĨ¤ āĻ•āĻžāϰāĻŖ, āϕ⧋āĻ­āĻŋāĻĄ-⧧⧝ āϝ⧇āĻšā§‡āϤ⧁ āϏāĻ‚āĻ•ā§āϰāĻžāĻŽāĻ•, āϏ⧇āĻšā§‡āϤ⧁ āϗ⧁āϜāĻŦ⧇āϰ āĻ•āĻžāϰāϪ⧇ āĻ­āĻžāχāϰāĻžāϏ⧇āϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻŦā§‡ā§œā§‡ āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻžāϤ⧇ āĻŽāĻžāύ⧁āώ āϏāĻžāĻŽāĻžāϜāĻŋāĻ• āĻ“ āĻ…āĻ°ā§āĻĨāύ⧈āϤāĻŋāĻ•āĻ­āĻžāĻŦ⧇ āĻ…āύ⧇āĻ• āĻŦ⧇āĻļāĻŋ āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻžāχ āĻ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϗ⧁āϜāĻŦ āϕ⧀, āϕ⧀āĻ­āĻžāĻŦ⧇ āĻ›ā§œāĻžā§Ÿ, āϕ⧇āύ āĻ›ā§œāĻžā§Ÿ āĻāĻŦāĻ‚ āϗ⧁āϜāĻŦ āĻ“ āφāϤāĻ™ā§āĻ• āϕ⧀āĻ­āĻžāĻŦ⧇ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻ•āϰāĻž āϝāĻžā§Ÿ, āϏ⧇ āĻŦāĻŋāĻˇā§Ÿā§‡ āφāϞ⧋āϚāύāĻž āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
āϗ⧁āϜāĻŦ āϕ⧀?
āĻŽāύ⧋āĻŦāĻŋāĻœā§āĻžāĻžāύ⧀āĻĻ⧇āϰ āĻŽāϤ⧇, ‘āϗ⧁āϜāĻŦ āĻšāϞ⧋ āĻāĻ•āϟāĻŋ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϘāϟāύāĻžāϕ⧇ āϕ⧇āĻ¨ā§āĻĻā§āϰ āĻ•āϰ⧇ āĻ•āĻŽāĻŋāωāύāĻŋāϟāĻŋāϰ āĻŽāĻžāύ⧁āώ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻ›ā§œāĻŋā§Ÿā§‡ āĻĒ⧜āĻž āĻāĻ•āϟāĻŋ āĻ—āĻ˛ā§āĻĒ, āϝāĻž āϏāĻ¤ā§āϝ-āĻŽāĻŋāĻĨā§āϝāĻžāϰ āĻŽāĻžāĻĒāĻ•āĻžāĻ āĻŋāϤ⧇ āϝāĻžāϚāĻžāχāĻ•ā§ƒāϤ āύāĻžāĨ¤â€™ āϕ⧋āύ⧋ āĻŦāĻŋāώ⧟ āύāĻŋā§Ÿā§‡ āĻāĻ•āĻŦāĻžāϰ āϗ⧁āϜāĻŦ āωāĻ āϞ⧇ āϤāĻž āĻ›ā§œāĻŋā§Ÿā§‡ āĻĻ⧇āĻ“ā§ŸāĻžāϰ āϜāĻ¨ā§āϝ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āϕ⧋āύ⧋ āĻĒā§āϰāĻšā§‡āĻˇā§āϟāĻžāϰ āĻĻāϰāĻ•āĻžāϰ āĻšā§Ÿ āύāĻžāĨ¤ āĻ•āĻžāϰāĻŖ, āĻŽāĻžāύ⧁āώ⧇āϰ āĻŽā§āϖ⧇ āĻŽā§āϖ⧇ āϤāĻž āĻ¸ā§āĻŦ⧟āĻ‚āĻ•ā§āϰāĻŋ⧟āĻ­āĻžāĻŦ⧇ āĻ›ā§œāĻŋā§Ÿā§‡ āĻĒā§œā§‡āĨ¤ āĻ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϗ⧁āϜāĻŦ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ⧇āϰ āĻšā§‡ā§Ÿā§‡āĻ“ āĻĻā§āϰ⧁āϤ āĻ›ā§œāĻžāϤ⧇ āϏāĻ•ā§āώāĻŽāĨ¤ āϕ⧋āύ⧋ āĻŦāĻŋāώ⧟ āύāĻŋā§Ÿā§‡ āĻŽāĻžāύ⧁āώ āϝāĻ–āύ āφāϤāĻ™ā§āĻ•āĻŋāϤ, āĻ­ā§€āϤ āĻ“ āĻĻ⧁āĻļā§āϚāĻŋāĻ¨ā§āϤāĻžā§Ÿ āĻĨāĻžāϕ⧇, āϤāĻ–āύāχ āϝ⧇āϕ⧋āύ⧋ āϗ⧁āϜāĻŦ āĻĻā§āϰ⧁āϤ āĻ›ā§œāĻžāϤ⧇ āϏāĻ•ā§āώāĻŽ āĻšā§ŸāĨ¤ āĻ•āĻžāϰāĻŖ, āĻāχ āϏāĻŽā§Ÿ āĻŽāĻžāύ⧁āώ⧇āϰ āĻŽāύ āĻŦāĻžāĻ›āĻŦāĻŋāϚāĻžāϰ āύāĻž āĻ•āϰ⧇ āϝ⧇āϕ⧋āύ⧋ āĻ•āĻŋāϛ⧁ āϏāĻšāĻœā§‡āχ āĻŦāĻŋāĻļā§āĻŦāĻžāϏ āĻ•āϰāĻžāϰ āϜāĻ¨ā§āϝ āωāĻĻā§â€ŒāĻ—ā§āϰ⧀āĻŦ āĻĨāĻžāϕ⧇āĨ¤ āϗ⧁āϜāĻŦ āϤ⧈āϰāĻŋ āĻ“ āĻ›ā§œāĻžāύ⧋āϰ āϜāĻ¨ā§āϝ āĻĻ⧁āϟāĻŋ āωāĻĒāĻžāĻĻāĻžāύ āĻ…āĻŦāĻļā§āϝāχ āĻāĻ•āϏāĻ™ā§āϗ⧇ āĻĨāĻžāĻ•āϤ⧇ āĻšā§ŸāĨ¤ āĻĒā§āϰāĻĨāĻŽāϤ, āϝ⧇ āϘāϟāύāĻž āĻŦāĻž āĻŦāĻŋāώ⧟āϕ⧇ āϕ⧇āĻ¨ā§āĻĻā§āϰ āĻ•āϰ⧇ āϗ⧁āϜāĻŦ āϤ⧈āϰāĻŋ āĻšāĻŦ⧇, āϏ⧇āχ āϘāϟāύāĻž āϜāύāϏāĻžāϧāĻžāϰāϪ⧇āϰ āĻ•āĻžāϛ⧇ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻšāϤ⧇ āĻšāĻŦ⧇āĨ¤ āĻĻā§āĻŦāĻŋāĻ¤ā§€ā§ŸāϤ, āĻ“āχ āϘāϟāύāĻž āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āϜāύāϏāĻžāϧāĻžāϰāϪ⧇āϰ āĻ•āĻžāϛ⧇ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āϕ⧋āύ⧋ āϧāĻžāϰāĻŖāĻž āĻ“ āϝāĻĨāĻžāϝāĻĨ āϕ⧋āύ⧋ āϤāĻĨā§āϝ āĻĨāĻžāĻ•āĻŦ⧇ āύāĻžāĨ¤

āϜāύāϏāĻžāϧāĻžāϰāϪ⧇āϰ āĻ…āϤāĻŋ āĻ‰ā§ŽāϏāĻžāĻš, āĻĢā§āϝāĻžāĻ¨ā§āϟāĻžāϏāĻŋ, āϝ⧌āύ āĻ…āĻŦāĻĻāĻŽāύ āĻ“ āĻšāϤāĻžāĻļāĻž, āĻĒā§āϰāϤāĻŋāĻļā§‹āϧāĻĒāϰāĻžā§ŸāĻŖ āĻ…āύ⧁āĻ­ā§‚āϤāĻŋāϰ āĻĒā§āϰāϤāĻŋāĻĢāϞāύ, āϘ⧃āĻŖāĻžāϰ āĻŦāĻšāĻŋāσāĻĒā§āϰāĻ•āĻžāĻļ, āϏ⧁āĻĒā§āϤ āχāĻšā§āĻ›āĻž āĻ“ āĻĒā§āϰāĻ¤ā§āϝāĻžāĻļāĻžāϰ āĻĒā§āϰāϤāĻŋāĻĢāϞāύ, āϏāĻŽāϏāĻžāĻŽā§ŸāĻŋāĻ• āϭ⧟ āĻ“ āωāĻĻā§āĻŦ⧇āĻ—āϕ⧇ āϕ⧇āĻ¨ā§āĻĻā§āϰ āĻ•āϰ⧇ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āϧāϰāύ⧇āϰ āϗ⧁āϜāĻŦ āϤ⧈āϰāĻŋ āĻšā§Ÿ āĻāĻŦāĻ‚ āĻ›ā§œāĻŋā§Ÿā§‡ āĻĒā§œā§‡āĨ¤ āĻ āĻ›āĻžā§œāĻž āĻŽāĻžāύ⧁āώ āϝ⧇ āϏāĻŽāĻžāĻœā§‡ āĻŦāĻžāϏ āĻ•āϰ⧇, āϏ⧇āχ āϏāĻŽāĻžāĻœā§‡āϰ āϏāĻžāĻŽāĻžāϜāĻŋāĻ• āĻ…āĻŦāĻ•āĻžāĻ āĻžāĻŽā§‹ āĻŦāĻž āϏāĻžāĻŽāĻžāϜāĻŋāĻ• āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻžāύāϗ⧁āϞ⧋āϰ (āĻĨāĻžāύāĻž, āφāχāύ, āφāĻĻāĻžāϞāϤ āχāĻ¤ā§āϝāĻžāĻĻāĻŋ) āĻ“āĻĒāϰ āĻŽāĻžāύ⧁āώ⧇āϰ āφāĻ¸ā§āĻĨāĻž āύāĻž āĻĨāĻžāĻ•āϞ⧇, āĻŽāĻžāύ⧁āώ⧇āϰ āϏāĻ™ā§āϗ⧇ āĻŽāĻžāύ⧁āώ⧇āϰ āĻŽāĻžāύāĻŦāĻŋāĻ• āϏāĻŽā§āĻĒāĻ°ā§āĻ• āύāĻž āĻĨāĻžāĻ•āϞ⧇, āϏ⧇āχ āϏāĻŽāĻžāĻœā§‡āϰ āĻŽāĻžāύ⧁āώ⧇āϰ āϝ⧇āϕ⧋āύ⧋ āϗ⧁āϜāĻŦ⧇ āϏāĻšāĻœā§‡āχ āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻšāĻ“ā§ŸāĻžāϰ āφāĻļāĻ™ā§āĻ•āĻž āĻŦ⧇āĻļāĻŋ āĻĨāĻžāϕ⧇āĨ¤
āϗ⧁āϜāĻŦ āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇āϰ āĻāĻ•āϟāĻŋ āĻĒāϰāĻŋāϚāĻŋāϤ āĻŦāĻŋāώ⧟āĨ¤ āĻ•āĻžāϰāϪ⧇-āĻ…āĻ•āĻžāϰāϪ⧇ āĻāĻ–āĻžāύ⧇ āϗ⧁āϜāĻŦ āϤ⧈āϰāĻŋ āĻšā§ŸāĨ¤ āĻ¸ā§āĻŦāĻĒā§āύ⧇ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ⧇āϰ āĻ­ā§āϝāĻžāĻ•āϏāĻŋāύ āϤ⧈āϰāĻŋāϰ āĻĢāĻ°ā§āĻŽā§āϞāĻž āĻĒāĻžāĻ“ā§ŸāĻž, āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇ āĻĨāĻžāύāϕ⧁āύāĻŋāĻĒāĻžāϤāĻžāϰ āĻŦā§āϝāĻŦāĻšāĻžāϰ āχāĻ¤ā§āϝāĻžāĻĻāĻŋ āϗ⧁āϜāĻŦ⧇āϰ āĻœā§āĻŦāϞāĻ¨ā§āϤ āωāĻĻāĻžāĻšāϰāĻŖ, āϝ⧇āϗ⧁āϞ⧋āϰ āϏāĻ¤ā§āϝāϤāĻž āύāĻž āĻĨāĻžāĻ•āĻž āϏāĻ¤ā§āĻ¤ā§āĻŦ⧇āĻ“ āĻŽāĻžāύ⧁āώ āĻŦāĻŋāĻļā§āĻŦāĻžāϏ āĻ•āϰ⧇āϛ⧇ āĻāĻŦāĻ‚ āĻšā§ŸāϤ⧋ āĻ­āĻŦāĻŋāĻˇā§āϝāϤ⧇āĻ“ āĻ•āϰāĻŦ⧇āĨ¤
āχāĻĻāĻžāύ⧀āĻ‚ āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āϗ⧁āϜāĻŦ⧇āϰ āĻāĻ•āϟāĻŋ āύāϤ⧁āύ āφāĻ•āĻžāϰ āĻĻ⧇āĻ–āĻž āϝāĻžāĻšā§āϛ⧇āĨ¤ āφāϰ āϏ⧇āϟāĻŋ āĻšāϞ⧋ āĻ…āĻ°ā§āĻĨāύ⧈āϤāĻŋāĻ• āϗ⧁āϜāĻŦāĨ¤ āĻŦ⧇āĻļ āĻ•āĻŋāϛ⧁āĻĻāĻŋāύ āφāϗ⧇ āĻšāĻ āĻžā§Ž āĻļā§‹āύāĻž āϗ⧇āϞ, āϚāĻŸā§āϟāĻ—ā§āϰāĻžāĻŽā§‡ āϞāĻŦāϪ⧇āϰ āϏāĻ‚āĻ•āϟ āĻĻ⧇āĻ–āĻž āĻĻāĻŋā§Ÿā§‡āϛ⧇āĨ¤ āϏāĻ™ā§āϗ⧇ āϏāĻ™ā§āϗ⧇ āĻĸāĻžāĻ•āĻžāϰ āĻŽāĻžāύ⧁āώ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ⧇āϰ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āϞāĻŦāĻŖ āĻ•āĻŋāύ⧇ āĻĻā§‹āĻ•āĻžāύāϗ⧁āϞ⧋ āϞāĻŦāĻŖāĻļā§‚āĻ¨ā§āϝ āĻ•āϰ⧇ āĻĢ⧇āϞāϞāĨ¤ āĻ•āĻŋāϛ⧁āĻĻāĻŋāύ āϧāϰ⧇ āĻļā§‹āύāĻž āϝāĻžāĻšā§āϛ⧇, āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏāϕ⧇ āϕ⧇āĻ¨ā§āĻĻā§āϰ āĻ•āϰ⧇ āĻ–āĻžāĻĻā§āϝāϏāĻ‚āĻ•āϟ āĻĻ⧇āĻ–āĻž āĻĻ⧇āĻŦ⧇āĨ¤ āϝāĻĻāĻŋāĻ“ āϏāϰāĻ•āĻžāϰ āĻŦāĻžāϰāĻŦāĻžāϰ āĻŦāϞ⧇ āφāϏāϛ⧇, āĻ–āĻžāĻĻā§āϝāϏāĻ‚āĻ•āϟ āĻĻ⧇āĻ–āĻž āĻĻ⧇āĻ“ā§ŸāĻžāϰ āϕ⧋āύ⧋ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž āύ⧇āχāĨ¤ āĻ•āĻžāϰāĻŖ, āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āĻ–āĻžāĻĻā§āϝāĻļāĻ¸ā§āϝ āφāϛ⧇āĨ¤ āĻ•āĻŋāĻ¨ā§āϤ⧁ āϕ⧇ āĻļā§‹āύ⧇ āĻ•āĻžāϰ āĻ•āĻĨāĻž! āĻāϰāχ āĻŽāĻ§ā§āϝ⧇ āĻŽāĻžāύ⧁āώ āύāĻŋāĻ¤ā§āϝāĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ āϜāĻŋāύāĻŋāϏāĻĒāĻ¤ā§āϰ āĻŽāϜ⧁āϤ āĻ•āϰāĻž āĻļ⧁āϰ⧁ āĻ•āϰ⧇ āĻĻāĻŋā§Ÿā§‡āϛ⧇āĨ¤ āĻĢāϞ⧇ āĻŦāĻžāϜāĻžāϰ⧇ āϜāĻŋāύāĻŋāϏāĻĒāĻ¤ā§āϰ⧇āϰ āĻĻāĻžāĻŽ āĻšā§ āĻšā§ āĻ•āϰ⧇ āĻŦāĻžā§œāϛ⧇āĨ¤
āϗ⧁āϜāĻŦ āĻ“ āφāϤāĻ™ā§āĻ• āĻĨ⧇āϕ⧇ āĻŦāĻžāρāϚāĻžāϰ āωāĻĒāĻžā§Ÿ āϕ⧀?

āĻ āϧāϰāύ⧇āϰ āϗ⧁āϜāĻŦ āĻ“ āφāϤāĻ™ā§āĻ• āĻĨ⧇āϕ⧇ āύāĻŋāĻœā§‡āĻĻ⧇āϰ āĻŦāĻžāρāϚāĻžāύ⧋āϰ āϜāĻ¨ā§āϝ āϝ⧇ āĻŦāĻŋāώ⧟ āĻāĻ–āύ āϏāĻŦāĻšā§‡ā§Ÿā§‡ āĻŦ⧇āĻļāĻŋ āϜāϰ⧁āϰāĻŋ, āϤāĻž āĻšāϞ⧋ āĻāϏāĻŦ⧇āϰ āĻŦāĻŋāĻĒāϰ⧀āϤ⧇ ‘āĻŽā§‡āĻ¨ā§āϟāĻžāϞ āχāĻŽāĻŋāωāύ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽâ€™ āĻŦāĻž āĻŽāĻžāύāϏāĻŋāĻ•āĻ­āĻžāĻŦ⧇ āĻĒā§āϰāϤāĻŋāϰ⧋āϧāĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻž āĻ—ā§œā§‡ āϤ⧋āϞāĻžāĨ¤ āύāĻŋāĻœā§‡āĻĻ⧇āϰ āĻŽāĻžāύāϏāĻŋāĻ• āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ⧇āϰ āĻĒā§āϰāϤāĻŋ āφāϞāĻžāĻĻāĻžāĻ­āĻžāĻŦ⧇ āύāϜāϰ āĻĻ⧇āĻ“ā§ŸāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤ āĻāχ āϏāĻŽā§Ÿ āφāĻĒāύāĻžāϰ āĻŽāĻžāύāϏāĻŋāĻ• āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āϝāϤ āĻŦ⧇āĻļāĻŋ āĻ­āĻžāϞ⧋ āĻĨāĻžāĻ•āĻŦ⧇, āφāĻĒāύāĻžāϰ āĻļāϰ⧀āϰ⧇ āϰ⧋āĻ— āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻ•ā§āώāĻŽāϤāĻž āϤāϤ āĻŦ⧇āĻļāĻŋ āĻ­āĻžāϞ⧋ āĻ•āĻžāϜ āĻ•āϰāĻŦ⧇āĨ¤ āϤāĻ–āύ āφāĻĒāύāĻžāϰ āĻŽāύ āϏāĻ āĻŋāĻ•āĻ­āĻžāĻŦ⧇ āϏāĻŦ āϧāϰāύ⧇āϰ āĻ–āĻžāϰāĻžāĻĒ āĻĒāϰāĻŋāĻ¸ā§āĻĨāĻŋāϤāĻŋ āĻŽā§‹āĻ•āĻžāĻŦāĻŋāϞāĻž āĻ•āϰāϤ⧇ āϏāĻ•ā§āώāĻŽ āĻšāĻŦ⧇āĨ¤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĻŦāĻŋāĻœā§āĻžāĻžāύ āϤāĻžâ€“āχ āĻŦāϞ⧇āĨ¤
āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āύāĻŋā§Ÿā§‡ āϭ⧟, āωāĻĻā§āĻŦ⧇āĻ—, āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ, āφāϤāĻ™ā§āĻ• āĻŽāĻžāύ⧁āώ⧇āϰ āĻŽāύ⧇ āĻŦāĻžā§œāϤ⧇ āĻĨāĻžāĻ•āϞ⧇ āĻāĻŦāĻ‚ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāĻ¸â€“āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āϏāĻ āĻŋāĻ• āĻ“ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āϤāĻĨā§āϝ āĻŽāĻžāύ⧁āώ⧇āϰ āĻ•āĻžāϛ⧇ āύāĻž āĻĒ⧌āρāĻ›āĻžāϞ⧇ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āϧāϰāύ⧇āϰ āϗ⧁āϜāĻŦ āĻŦāĻžāϜāĻžāϰ⧇ āφāϏāĻŦ⧇ āĻāĻŦāĻ‚ āĻŽāĻžāύ⧁āώ āĻ—āĻŖāĻšāĻžāϰ⧇ āϤāĻžāϤ⧇ āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻšāĻŦ⧇āĨ¤ āϤāĻžāχ āφāĻŽāĻžāĻĻ⧇āϰ āĻāĻ•āĻĻāĻŋāϕ⧇ āϭ⧟, āωāĻĻā§āĻŦ⧇āĻ—, āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻ“ āφāϤāĻ™ā§āĻ•āϕ⧇ āĻŽāĻžāύāϏāĻŋāĻ•āĻ­āĻžāĻŦ⧇ āϏāĻžāĻŽāĻžāϞ āĻĻāĻŋāϤ⧇ āĻšāĻŦ⧇āĨ¤ āĻ…āĻ¨ā§āϝāĻĻāĻŋāϕ⧇ āĻ…āύāϞāĻžāχāύ āĻ“ āĻ…āĻĢāϞāĻžāχāύ⧇ āĻ›ā§œāĻŋā§Ÿā§‡â€“āĻ›āĻŋāϟāĻŋā§Ÿā§‡ āĻĨāĻžāĻ•āĻž āĻšāĻžāϜāĻžāϰ āĻšāĻžāϜāĻžāϰ āϤāĻĨā§āϝ āĻĨ⧇āϕ⧇ āύāĻŋāĻ°ā§āĻ­āϰāϝ⧋āĻ—ā§āϝ āϤāĻĨā§āϝāϗ⧁āϞ⧋ āĻŦāĻžāĻ›āĻžāχ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤ āϏāĻŦ āϧāϰāύ⧇āϰ āϤāĻĨā§āϝ⧇ āĻĒā§āϰāĻ­āĻžāĻŦāĻŋāϤ āĻšāĻ“ā§ŸāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤
āĻ•āϰ⧋āύāĻž āĻŽāĻšāĻžāĻŽāĻžāϰāĻŋāϕ⧇ āϕ⧇āĻ¨ā§āĻĻā§āϰ āĻ•āϰ⧇ āφāĻĒāύāĻžāϰ āĻŽāύ⧇ āϭ⧟, āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ, āωāĻĻā§āĻŦ⧇āĻ— āĻ•āĻžāϜ āĻ•āϰāĻŦ⧇, āĻāϟāĻžāχ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ•āĨ¤ āϝ⧌āĻ•ā§āϤāĻŋāĻ• āĻĒāĻ°ā§āϝāĻžā§Ÿā§‡āϰ āϭ⧟, āϚāĻžāĻĒ, āωāĻĻā§āĻŦ⧇āĻ— āφāĻĒāύāĻžāϰ āĻŽāĻ¸ā§āϤāĻŋāĻˇā§āĻ•/āĻŽāύāϕ⧇ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āĻ“ āĻ­āĻŦāĻŋāĻˇā§āϝāϤ⧇āϰ āĻ•āĻ āĻŋāύ āĻĒāϰāĻŋāĻ¸ā§āĻĨāĻŋāϤāĻŋ āϏāĻžāĻŽāĻžāϞ āĻĻ⧇āĻ“ā§ŸāĻžāϰ āϜāĻ¨ā§āϝ āĻĒā§āϰāĻ¸ā§āϤ⧁āϤ āĻ•āϰāĻŦ⧇āĨ¤ āĻ…āĻ¨ā§āϝāĻĻāĻŋāϕ⧇ āĻŽāĻžāĻ¤ā§āϰāĻžāϤāĻŋāϰāĻŋāĻ•ā§āϤ āύ⧇āϤāĻŋāĻŦāĻžāϚāĻ• āφāĻŦ⧇āĻ— (āĻŦ⧇āĻļāĻŋ āϭ⧟), āύ⧇āϤāĻŋāĻŦāĻžāϚāĻ• āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ (āĻŦ⧇āĻļāĻŋ āĻĻā§āĻŦāĻŋāϧāĻž-āĻĻā§āĻŦāĻ¨ā§āĻĻā§āĻŦ), āύ⧇āϤāĻŋāĻŦāĻžāϚāĻ• āϚāĻŋāĻ¨ā§āϤāĻžā§Ÿ (āφāĻŽāĻžāĻĻ⧇āϰ āĻ•āĻŋāϛ⧁āχ āĻ•āϰāĻžāϰ āύ⧇āχ āϧāϰāύ⧇āϰ) āφāĻĒāύāĻŋ āϝāϤ āĻŦ⧇āĻļāĻŋ āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻšāĻŦ⧇āύ, āϤāϤ āĻŦ⧇āĻļāĻŋ āϗ⧁āϜāĻŦ āĻ“ āφāϤāĻ™ā§āϕ⧇ āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻšāĻŦ⧇āύāĨ¤
āϚāϞāĻŽāĻžāύ āĻ…āĻĨāĻŦāĻž āφāϏāĻ¨ā§āύ āĻŦāĻŋāĻĒāĻĻāϕ⧇ āϕ⧇āĻ¨ā§āĻĻā§āϰ āĻ•āϰ⧇ āĻŽāĻžāύ⧁āώ⧇āϰ āĻŽāύ⧇ āĻĻ⧁āχ āϧāϰāύ⧇āϰ āϭ⧟ āĻ‰ā§ŽāĻĒāĻ¨ā§āύ āĻšā§ŸāĨ¤ āĻāĻ•āϟāĻŋ āĻšāϞ⧋ āϝ⧌āĻ•ā§āϤāĻŋāĻ• āϭ⧟, āĻ…āĻ¨ā§āϝāϟāĻŋ āĻšāϞ⧋ āĻ…āϝ⧌āĻ•ā§āϤāĻŋāĻ• āϭ⧟āĨ¤ āϝ⧌āĻ•ā§āϤāĻŋāĻ• āϭ⧟ āφāĻŽāĻžāĻĻ⧇āϰ āĻŽāύ āĻ“ āĻļāϰ⧀āϰāϕ⧇ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏāϕ⧇ āĻŽā§‹āĻ•āĻžāĻŦāĻŋāϞāĻž āĻ•āϰāĻžāϰ āϜāĻ¨ā§āϝ āĻĒā§āϰāĻ¸ā§āϤ⧁āϤ āĻ•āϰāĻŦ⧇āĨ¤ āĻ…āĻ¨ā§āϝāĻĻāĻŋāϕ⧇ āĻ…āϝ⧌āĻ•ā§āϤāĻŋāĻ• āϭ⧟ āφāĻŽāĻžāĻĻ⧇āϰ āϭ⧇āϤāϰ āύ⧇āϤāĻŋāĻŦāĻžāϚāĻ• āφāĻŦ⧇āĻ— āĻ“ āφāϚāϰāĻŖ āϤ⧈āϰāĻŋ āĻ•āϰāĻŦ⧇āĨ¤ āĻŽāύ āĻ“ āĻļāϰ⧀āϰāϕ⧇ āĻĻ⧁āĻ°ā§āĻŦāϞ āĻ•āϰ⧇ āĻĢ⧇āϞāĻŦ⧇āĨ¤ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āĻŦ⧈āĻœā§āĻžāĻžāύāĻŋāĻ• āϤāĻĨā§āϝ āύāĻž āĻĒ⧇āϞ⧇ āĻŽāĻžāύ⧁āώ⧇āϰ āĻŽāύ⧇ āĻ…āϝ⧌āĻ•ā§āϤāĻŋāĻ• āϭ⧟ āĻŦ⧇āĻļāĻŋ āĻ•āĻžāϜ āĻ•āϰāĻŦ⧇āĨ¤ āĻ…āϝ⧌āĻ•ā§āϤāĻŋāĻ• āϭ⧟āϕ⧇ āϕ⧇āĻ¨ā§āĻĻā§āϰ āĻ•āϰ⧇ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āϗ⧁āϜāĻŦ āĻ›ā§œāĻžāĻŦ⧇āĨ¤ āϗ⧁āϜāĻŦ āϝ⧇āϕ⧋āύ⧋ āĻĒāϰāĻŋāĻ¸ā§āĻĨāĻŋāϤāĻŋāϕ⧇ āϖ⧁āĻŦ āϏāĻšāĻœā§‡āχ āϭ⧟āĻžāĻŦāĻšāϤāĻžāϰ āĻĻāĻŋāϕ⧇ āύāĻŋā§Ÿā§‡ āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϚāĻžāϰāĻĒāĻžāĻļ⧇ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āϗ⧁āϜāĻŦ āĻāϰ āĻŽāĻ§ā§āϝ⧇āχ āϤ⧈āϰāĻŋ āĻšā§Ÿā§‡āϛ⧇āĨ¤ āϏ⧁āϤāϰāĻžāĻ‚ āĻ…āϝ⧌āĻ•ā§āϤāĻŋāĻ• āϭ⧟ āĻ“ āϗ⧁āϜāĻŦ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇āϰ āϜāĻ¨ā§āϝ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āϏāĻ āĻŋāĻ• āϤāĻĨā§āϝ āϜāĻžāύ⧁āύ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āĻ“ āϰ⧋āĻ— āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžāĻĻ⧇āϰ āĻ•āĻžāĻ› āĻĨ⧇āϕ⧇āĨ¤ āĻ…āĻĨāĻŦāĻž āĻŦāĻŋāĻļā§āĻŦ āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āϏāĻ‚āĻ¸ā§āĻĨāĻžāϰ āĻ•āĻžāĻ› āĻĨ⧇āϕ⧇āĨ¤
āφāĻĒāύāĻŋ āϝāĻĻāĻŋ āĻŽāύ⧇ āĻ•āϰ⧇āύ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ⧇āϰ āĻ•āĻžāϰāϪ⧇ āϏ⧃āĻˇā§āϟ āĻĒāϰāĻŋāĻ¸ā§āĻĨāĻŋāϤāĻŋ āĻŽā§‹āĻ•āĻžāĻŦāĻŋāϞāĻž āĻ•āϰāĻžāϰ āϜāĻ¨ā§āϝ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āϏāĻ•ā§āώāĻŽāϤāĻž āφāĻĒāύāĻžāϰ āĻšāĻžāϤ⧇ āύ⧇āχ, āϤāĻŦ⧇ āφāĻĒāύāĻŋ āĻāχ āϏāĻŽā§Ÿ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ⧇ āϭ⧁āĻ—āϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤ āĻ āϧāϰāύ⧇āϰ āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻŽā§‹āĻ•āĻžāĻŦāĻŋāϞāĻž āĻ•āϰāĻžāϰ āϜāĻ¨ā§āϝ āφāĻĒāύāĻŋ āφāĻĒāύāĻžāϰ āĻĒāϰāĻŋāĻŦāĻžāϰāϕ⧇ āĻāĻŽāύāĻ­āĻžāĻŦ⧇ āϏāĻŽā§Ÿ āĻĻ⧇āĻŦ⧇āύ, āϝ⧇āύ āϤāĻžāĻĻ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻĨāĻžāĻ•āĻž āφāϤāĻ™ā§āĻ• āĻ•āĻŽā§‡ āφāϏ⧇āĨ¤ āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ āφāĻļāĻĒāĻžāĻļ⧇āϰ āφāĻ¤ā§āĻŽā§€ā§ŸāĻ¸ā§āĻŦāϜāύ āĻ“ āĻŦāĻ¨ā§āϧ⧁āĻĻ⧇āϰ āϏāĻ™ā§āϗ⧇ āĻ­āĻžāĻ°ā§āĻšā§āϝ⧁⧟āĻžāϞ āϝ⧋āĻ—āĻžāϝ⧋āĻ— āĻŦāĻžā§œāĻžāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤ āĻāϤ⧇ āĻāĻ•āϟāĻž āĻ—āĻ­ā§€āϰ āĻŽāĻžāύāĻŦāĻŋāĻ• āĻŦāĻ¨ā§āϧāύ āĻ…āύ⧁āĻ­āĻŦ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤ āĻāĻ­āĻžāĻŦ⧇ āφāĻĒāύāĻžāϰ āĻšāĻžāϤ⧇ āϝāϤāϟ⧁āϕ⧁ āϏāĻ•ā§āώāĻŽāϤāĻž āĻ°ā§Ÿā§‡āϛ⧇, āϤāϤāϟ⧁āϕ⧁āϰ āϏāĻ°ā§āĻŦā§‹āĻ¤ā§āϤāĻŽ āĻŦā§āϝāĻŦāĻšāĻžāϰ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤ āĻĒāϰāĻŋāĻŦāĻžāϰ⧇āϰ āϏāĻĻāĻ¸ā§āϝāĻĻ⧇āϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻŽā§‹āϤāĻžāĻŦ⧇āĻ• āĻļ⧁āĻ•āύ⧋ āĻ–āĻžāĻŦāĻžāϰ āĻ“ āϏāĻžāϧāĻžāϰāĻŖ āĻ“āώ⧁āϧ⧇āϰ āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻž āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤ āĻāχ āϏāĻŽā§Ÿ āĻŦ⧇āĻļāĻŋ āϞ⧋āϕ⧇āϰ āϏāĻŽāĻžāĻ—āĻŽ āĻā§œāĻŋā§Ÿā§‡ āĻŦāĻžā§œāĻŋāϰ āϭ⧇āϤāϰ āύāĻŋ⧟āĻŽāĻŋāϤ āύāĻžāĻŽāĻžāϜ, āĻĒā§āϰāĻžāĻ°ā§āĻĨāύāĻž āĻ“ āĻ§ā§āϝāĻžāύ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤ āĻāϤ⧇ āĻŽāύ āϚāĻžāĻ™āĻž āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
āφāϤāĻ™ā§āĻ• āĻ“ āωāĻĻā§āĻŦ⧇āĻ— āĻ•āĻŽāĻžāĻŦ⧇āύ āϝ⧇āĻ­āĻžāĻŦ⧇

āĻ…āϧāĻŋāĻ• āϜāύāϏāĻ‚āĻ–ā§āϝāĻžāϰ āĻĒā§āϰāĻ­āĻžāĻŦ āĻāĻŦāĻ‚ āĻ…āĻĒā§āϰāϤ⧁āϞ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻžāϰ āĻ•āĻžāϰāϪ⧇ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āύāĻŋā§Ÿā§‡ āφāĻĒāύāĻžāϰ āĻŽāύ⧇ āωāĻĻā§āĻŦ⧇āĻ— āϤ⧈āϰāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻŽā§‚āϞāϤ, āĻ­āĻŦāĻŋāĻˇā§āĻ¯ā§Ž āĻ…āύāĻŋāĻļā§āϚ⧟āϤāĻž āĻĨ⧇āϕ⧇āχ āĻŽāĻžāύ⧁āώ⧇āϰ āĻŽāύ⧇ āωāĻĻā§āĻŦ⧇āĻ— āϤ⧈āϰāĻŋ āĻšā§ŸāĨ¤ āĻāχ āωāĻĻā§āĻŦ⧇āĻ— āϖ⧁āĻŦāχ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ•āĨ¤ āφāĻĒāύāĻžāϰ āĻŽāύ⧇āϰ āϭ⧇āϤāϰ āĻ āϧāϰāύ⧇āϰ āωāĻĻā§āĻŦ⧇āĻ— āĻ•āĻžāϜ āĻ•āϰāϞ⧇ āĻĒā§āϰāĻĨāĻŽā§‡āχ āϏ⧇āχ āĻ…āύ⧁āĻ­ā§‚āϤāĻŋāϕ⧇ āĻ¸ā§āĻŦā§€āĻ•āĻžāϰ āĻ•āϰ⧇ āύāĻŋāύāĨ¤ āĻĻā§€āĻ°ā§āϘ āĻāĻ•āϟāĻŋ āύāĻŋāĻļā§āĻŦāĻžāϏ āύāĻŋāύāĨ¤ āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ āφāĻĒāύāĻžāϰ āĻāχ āĻ…āύ⧁āĻ­ā§‚āϤāĻŋāϰ āĻĒā§āϰāϤāĻŋ āύ⧇āϤāĻŋāĻŦāĻžāϚāĻ• āĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋ⧟āĻž āύāĻž āĻĻ⧇āĻ–āĻŋā§Ÿā§‡ āχāϤāĻŋāĻŦāĻžāϚāĻ• āĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋ⧟āĻž āĻĻ⧇āĻ–āĻžāύāĨ¤ āĻ•āĻžāϰāĻŖ, āωāĻĻā§āĻŦ⧇āϗ⧇āϰ āĻĒā§āϰāϤāĻŋ āφāĻĒāύāĻŋ āϝāĻĻāĻŋ āύ⧇āϤāĻŋāĻŦāĻžāϚāĻ• āĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋ⧟āĻž āĻĻ⧇āĻ–āĻžāύ, āϤāĻŦ⧇ āϏ⧇āϟāĻŋ āφāĻĒāύāĻžāϰ āĻļāϰ⧀āϰ⧇āϰ āĻ“āĻĒāϰ āĻ–āĻžāϰāĻžāĻĒ āĻĒā§āϰāĻ­āĻžāĻŦ āĻĢ⧇āϞāĻŦ⧇āĨ¤ āϝ⧇āĻŽāύ: āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āϘāĻžāĻŽ āĻšāĻŦ⧇, āĻŦ⧁āĻ• āϧ⧜āĻĢ⧜ āĻ•āϰāĻŦ⧇, āĻ…āĻ¸ā§āĻĨāĻŋāϰāϤāĻž āĻ­āϰ āĻ•āϰāĻŦ⧇ āχāĻ¤ā§āϝāĻžāĻĻāĻŋāĨ¤ āωāĻĻā§āĻŦ⧇āĻ— āĻŽā§‹āĻ•āĻžāĻŦāĻŋāϞāĻž āĻ•āϰāĻžāϰ āϜāĻ¨ā§āϝ āφāĻĒāύāĻŋ āĻ āĻŋāĻ• āϝ⧇ āĻĒāϰāĻŋāĻŦ⧇āĻļ⧇ āφāϛ⧇āύ, āϏ⧇āχ āĻĒāϰāĻŋāĻŦ⧇āĻļ⧇āϰ āχāϤāĻŋāĻŦāĻžāϚāĻ• āϕ⧋āύ⧋ āĻŦāĻ¸ā§āϤ⧁ āĻŦāĻž āĻŦāĻŋāĻˇā§Ÿā§‡āϰ āĻĒā§āϰāϤāĻŋ āĻŽāύāϕ⧇ āĻĒā§āϰāĻŦāĻžāĻšāĻŋāϤ āĻ•āϰ⧁āύāĨ¤ āϏāĻŽā§Ÿ āĻ•āĻžāϟāϤ⧇ āĻĻāĻŋāύāĨ¤ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āωāĻĻā§āĻŦ⧇āĻ— āφāĻĒāύāĻžāϰ āĻŽāύ āĻĨ⧇āϕ⧇ āĻ¸ā§āĻŦāϤāσāĻ¸ā§āĻĢā§‚āĻ°ā§āϤāĻ­āĻžāĻŦ⧇āχ āϚāϞ⧇ āϝāĻžāĻŦ⧇, āϝāĻĻāĻŋ āφāĻĒāύāĻŋ āĻ“āχ āϏāĻŽā§Ÿāϟ⧁āϕ⧁ āύāĻŋāĻœā§‡āϰ āωāĻĻā§āĻŦ⧇āϗ⧇āϰ āĻĒā§āϰāϤāĻŋ āύāĻŋāϰāĻĒ⧇āĻ•ā§āώ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āύ āĻāĻŦāĻ‚ āύāĻŋāĻœā§‡āϰ āĻ…āύ⧁āĻ­ā§‚āϤāĻŋāϰ āĻĒā§āϰāϤāĻŋ āύāĻŋāĻœā§‡āχ āĻŽāĻŽāϤāĻžāĻŦā§‹āϧ āĻĻ⧇āĻ–āĻžāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤
āϭ⧟, āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻ“ āωāĻĻā§āĻŦ⧇āĻ— āϝāĻĻāĻŋ āĻāĻ•āχ āϏāĻ™ā§āϗ⧇ āφāĻĒāύāĻžāϰ āĻŽāύāϕ⧇ āĻ—ā§āϰāĻžāϏ āĻ•āϰ⧇ āĻāĻŦāĻ‚ āφāĻĒāύāĻžāϰ āĻŽāύ āĻāχ āϤāĻŋāύāϟāĻŋ āύ⧇āϤāĻŋāĻŦāĻžāϚāĻ• āĻ…āύ⧁āĻ­ā§‚āϤāĻŋāϰ āĻŦāĻŋāϰ⧁āĻĻā§āϧ⧇ āϝāĻĻāĻŋ āϕ⧋āύ⧋ āĻĒā§āϰāϤāĻŋāϰ⧋āĻ§â€“āĻĻā§‡ā§ŸāĻžāϞ āϤ⧁āϞāϤ⧇ āύāĻž āĻĒāĻžāϰ⧇, āϤāĻŦ⧇ āφāĻĒāύāĻŋ āϝ⧇āϕ⧋āύ⧋ āϏāĻŽā§Ÿ āφāϤāĻ™ā§āĻ•āĻŋāϤ āĻšā§Ÿā§‡ āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤ āĻ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āφāĻĒāύāĻžāϰ āĻŦāĻŋāĻŦ⧇āĻ•, āĻŦ⧁āĻĻā§āϧāĻŋ, āĻŦā§‹āϧ, āϝ⧁āĻ•ā§āϤāĻŋ—āĻ•āĻŋāϛ⧁āχ āĻ āĻŋāĻ•āĻ āĻžāĻ• āĻ•āĻžāϜ āĻ•āϰāĻŦ⧇ āύāĻžāĨ¤ āφāϰ āĻāϏāĻŦ āĻŦāĻŋāώ⧟ āϏāĻ āĻŋāĻ•āĻ­āĻžāĻŦ⧇ āĻ•āĻžāϜ āύāĻž āĻ•āϰāϞ⧇ āφāĻĒāύāĻŋ āϏāĻšāĻœā§‡āχ āϗ⧁āϜāĻŦ⧇āϰ āĻļāĻŋāĻ•āĻžāϰ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤ āϝ⧇āϕ⧋āύ⧋ āĻŦāĻŋāĻˇā§Ÿā§‡ āφāĻĒāύāĻŋ āϝāĻĻāĻŋ āφāϤāĻ™ā§āĻ•āĻŋāϤ āύāĻž āĻšā§Ÿā§‡ āĻļāĻžāĻ¨ā§āϤ āĻĨāĻžāϕ⧇āύ, āĻ¸ā§āĻĨāĻŋāϰ āĻĨāĻžāϕ⧇āύ āĻāĻŦāĻ‚ āϏāĻžāĻŽāĻ—ā§āϰāĻŋāĻ• āĻŦāĻŋāώ⧟āϟāĻž āĻŦā§‹āĻāĻžāϰ āϜāĻ¨ā§āϝ āύāĻŋāĻœā§‡āϕ⧇ āϏāĻŽā§Ÿ āĻĻ⧇āύ, āϤāĻŦ⧇ āϗ⧁āϜāĻŦ⧇ āĻ“ āφāϤāĻ™ā§āϕ⧇ āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻšāĻ“ā§ŸāĻžāϰ āφāĻļāĻ™ā§āĻ•āĻž āĻ•āĻŽ āĻĨāĻžāϕ⧇āĨ¤
āϏāĻžāĻŽāĻžāϜāĻŋāĻ• āϝ⧋āĻ—āĻžāϝ⧋āϗ⧇āϰ āĻŽāĻžāĻ§ā§āϝāĻŽ, āĻ–āĻŦāϰ⧇āϰ āĻ•āĻžāĻ—āĻœā§‡, āĻ…āύāϞāĻžāχāύ āύāĻŋāωāϜ āĻĒā§‹āĻ°ā§āϟāĻžāϞāϗ⧁āϞ⧋ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ⧇āϰ āĻ–āĻŦāϰ⧇ āĻāĻ•āĻžāĻ•āĻžāϰāĨ¤ āϝ⧇ āϧāϰāύ⧇āϰ āĻŽāĻŋāĻĄāĻŋ⧟āĻž āĻŦāĻž āĻ–āĻŦāϰ⧇āϰ āĻŽāĻžāĻ§ā§āϝāĻŽ āφāĻĒāύāĻžāϰ āωāĻĻā§āĻŦ⧇āĻ—, āϭ⧟ āĻ“ āĻĻ⧁āĻļā§āϚāĻŋāĻ¨ā§āϤāĻž āĻŦāĻžā§œāĻŋā§Ÿā§‡ āĻĻā§‡ā§Ÿ, āϏ⧇āϗ⧁āϞ⧋ āĻā§œāĻŋā§Ÿā§‡ āϚāϞ⧁āύāĨ¤ āĻ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻĢ⧇āϏāĻŦ⧁āĻ• āϏāĻŦāĻšā§‡ā§Ÿā§‡ āĻŦāĻŋāĻĒāĻœā§āϜāύāĻ•āĨ¤ āϤāĻžāχ āĻ āϏāĻŽā§Ÿā§‡ āϏ⧋āĻļā§āϝāĻžāϞ āĻŽāĻŋāĻĄāĻŋ⧟āĻžāϰ āĻŦā§āϝāĻŦāĻšāĻžāϰ āϏ⧀āĻŽāĻŋāϤ āĻ•āϰ⧁āύāĨ¤ āĻšāϰ⧇āĻ• āϰāĻ•āĻŽ āĻ…āύāĻŋāĻ°ā§āĻ­āϰāϝ⧋āĻ—ā§āϝ āϤāĻĨā§āϝ āφāĻĒāύāĻžāϕ⧇ āφāϤāĻ™ā§āĻ•āĻŋāϤ āĻ•āϰ⧇ āϤ⧁āϞāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āφāĻĒāύāĻŋ āφāϤāĻ™ā§āĻ•āĻŋāϤ āĻšāϞ⧇ āϚāĻžāϰāĻĒāĻžāĻļ⧇āϰ āĻŽāĻžāύ⧁āώ āφāĻĒāύāĻžāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻĒā§āϰāĻ­āĻžāĻŦāĻŋāϤ āĻšā§Ÿā§‡ āφāϤāĻ™ā§āĻ•āĻŋāϤ āĻšā§Ÿā§‡ āϝāĻžāĻŦ⧇āĨ¤
āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āĻŽā§ŒāϞāĻŋāĻ• āϤāĻĨā§āϝāϗ⧁āϞ⧋ āϝāĻĻāĻŋ āφāĻĒāύāĻžāϰ āĻ•āĻžāϛ⧇ āĻĨāĻžāϕ⧇, āϤāĻŦ⧇ āĻ āϏāĻŽā§Ÿ āĻŦ⧇āĻļāĻŋ āϤāĻĨā§āϝ āφāĻĒāύāĻžāϰ āĻĻāϰāĻ•āĻžāϰ āύ⧇āχāĨ¤ āĻ•āĻžāϰāĻŖ, āĻŦ⧇āĻļāĻŋ āϤāĻĨā§āϝ (āχāϤāĻŋāĻŦāĻžāϚāĻ•/āύ⧇āϤāĻŋāĻŦāĻžāϚāĻ•) āύāĻŋāϞ⧇ āϤāĻž āφāĻĒāύāĻžāϰ āĻŽāύāϕ⧇ āĻĻ⧁āĻ°ā§āĻŦāϞ āĻ•āϰ⧇ āĻĻāĻŋāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āφāĻļāĻĒāĻžāĻļ⧇āϰ āφāĻ¤ā§āĻŽā§€ā§ŸāĻ¸ā§āĻŦāϜāύ āĻ“ āĻ•āĻŽāĻŋāωāύāĻŋāϟāĻŋāϰ āĻŽāĻžāύ⧁āώ⧇āϰ āϏāĻ™ā§āϗ⧇ āύāĻŋāϰāĻžāĻĒāĻĻ āωāĻĒāĻžā§Ÿā§‡ āϝ⧋āĻ—āĻžāϝ⧋āĻ— āĻŦāĻžā§œāĻžāϤ⧇ āĻšāĻŦ⧇āĨ¤ āĻāϤ⧇ āϏāĻŦāĻžāϰ āĻŽāĻ§ā§āϝ⧇ āϝ⧋āĻ—āĻžāϝ⧋āĻ— āĻ“ āĻšā§ƒāĻĻā§āϝāϤāĻž āĻŦāĻžā§œā§‡ āĻāĻŦāĻ‚ āϏāĻŦāĻžāχ āĻĒāϰāĻŋāĻ¸ā§āĻĨāĻŋāϤāĻŋ āĻŽā§‹āĻ•āĻžāĻŦāĻŋāϞāĻž āĻ•āϰāĻžāϰ āĻŽāϤ⧋ āφāĻ¤ā§āĻŽāĻŦāĻŋāĻļā§āĻŦāĻžāϏ āĻĒāĻžā§ŸāĨ¤ āĻĒāϰāĻŋāĻŦāĻžāϰ⧇āϰ āĻļāĻŋāĻļ⧁ āĻ“ āĻŦ⧃āĻĻā§āϧāĻĻ⧇āϰ āĻ•āϰ⧋āύāĻžāĻ­āĻžāχāϰāĻžāϏ āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āĻŦ⧈āĻœā§āĻžāĻžāύāĻŋāĻ• āϤāĻĨā§āϝ āϜāĻžāύāĻžāϤ⧇ āĻšāĻŦ⧇āĨ¤ āĻ āϏāĻŽā§Ÿ āϤāĻžāĻĻ⧇āϰ āĻĒā§āϰāϤāĻŋ āĻ­āĻžāϞ⧋āĻŦāĻžāϏāĻž āĻ“ āϝāĻ¤ā§āύāĻļā§€āϞ āĻĻ⧃āĻˇā§āϟāĻŋāĻ­āĻ™ā§āĻ—āĻŋ āύāĻŋāϤ⧇ āĻšāĻŦ⧇, āϝāĻžāϤ⧇ āϤāĻžāϰāĻž āφāϤāĻ™ā§āĻ•āĻŋāϤ āύāĻž āĻšā§ŸāĨ¤
āϏāĻŦ āĻļ⧇āώ⧇āϰ āĻ•āĻžāϜ āĻšāϞ⧋ āχāϤāĻŋāĻŦāĻžāϚāĻ• āĻŽāύāĻŽāĻžāύāϏāĻŋāĻ•āϤāĻžāϰ āĻ…āύ⧁āĻļā§€āϞāύ āĻ•āϰāĻžāĨ¤ āĻ…āĻ¨ā§āϝ āĻŽāĻžāύ⧁āώ⧇āϰ āĻĒā§āϰāϤāĻŋ, āύāĻŋāĻœā§‡āϰ āĻĒā§āϰāϤāĻŋ, āĻĒāϰāĻŋāĻŦāĻžāϰ⧇āϰ āĻĒā§āϰāϤāĻŋ, āĻĒā§āϰāĻ•ā§ƒāϤāĻŋāϰ āĻĒā§āϰāϤāĻŋ āχāϤāĻŋāĻŦāĻžāϚāĻ• āĻšāϤ⧇ āĻšāĻŦ⧇āĨ¤

Monday, March 23, 2020

The Coronavirus (COVID-19): Presently World most Threatened Virus now a days.


The Coronavirus (COVID-19) is an virulent disease occurred by severe acute respiratory syndrome coronavirus2. The outbreak was first identified in Wuhan, Hubei, China, in December 2019, and was recognised as a pandemic by the World Health Organization (WHO) on 11 March 2020. As of 23 March, more than 353,000 cases of COVID-19 have been reported in over 190 countries and territories, resulting in more than 15,400 deaths and more than 100,000 recoveries.

The virus is typically spread from one person to another via respiratory droplets produced during coughing.  Primarily, it spreads when people are in close contact but it may also spread when one touches a contaminated surface and then their eyes, nose or mouth. It is most contagious when people are symptomatic, although spread may be possible before symptoms appear. The time between exposure and symptom onset is typically around five days, but may range from two to fourteen days. Common symptoms include fever, cough, and shortness of breath. Complications may include pneumonia and acute respiratory distress syndrome. There is no vaccine or specific antiviral treatment. Primary treatment is symptomatic and supportive therapy. Recommended preventive measures include hand washing, covering the mouth when coughing, maintaining distance from other people, and monitoring and self-isolation for people who suspect they are infected.

Efforts to prevent the virus spreading include travel restrictions, quarantines, curfews, event postponements and cancellations, and facility closures. These include a quarantine of Hubei, nationwide quarantines in Italy and elsewhere in Europe, curfew measures elsewhere in China and South Korea, various border closures or incoming passenger restrictions, screening at airports and train stations, and travel advisories regarding regions with community transmission. Schools and universities have closed either on a nationwide or local basis in over 124 countries, affecting more than 1.2 billion students.

Symptoms of Coronavirus (COVID-19)

Symptoms of COVID-19 are non-specific and those infected may either be asymptomatic or develop flu-like symptoms such as fever, cough, fatigue, shortness of breath, or muscle pain. In my experience most of the cases COVID19 patient are suffering from fever with up to 1000 C temperature up to 4-5 days of virus infection with cough, fatigue. After five days fever temperature will increase and acute breathing problem will appear. The Centers for Disease Control and Prevention (CDC) lists emergency symptoms including difficulty breathing, persistent chest pain or pressure, sudden confusion, difficulty walking, and bluish face or lips; immediate medical attention is advised if these symptoms are present.
Further development of the disease can lead to severe pneumonia, acute respiratory distress syndrome, sepsis, septic shock and death. Some of those infected may be asymptomatic, returning test results that confirm infection but show no clinical symptoms, so researchers have issued advice that those with close contact to confirmed infected people should be closely monitored and examined to rule out infection.

The usual incubation period (the time between infection and symptom onset) ranges from one to fourteen days; it is most commonly five days. In one case, it may have had an incubation period of 27 days.

How to Transmit this Virus

The primary mode of spread is via respiratory droplets that people blow out or cough.  This is thought to take place when people are in close contact, often during coughing or sneezing. The European Centre for Disease Prevention and Control (ECDC) agree that it seems to increase via these droplets, but "there is not enough plausible information at this time [23 March] to determine how easily and sustainably this virus spreads between people." The strength of the SARS-CoV-2 virus in the air and on various surfaces is believed to be comparable to that of other coronaviruses. A single study of how long SARS-CoV-2 (COVID-19) remains infectious on various surfaces, "show[s] that when the virus is carried by the droplets released when someone coughs or sneezes, it remains viable, or able to still infect people, in aerosols for at least three hours.

"Prevention of this virus" is coming next post.........

Saturday, September 7, 2019

Plethora of Hilsha fish, Looooooook

ilisha (ilish)ilishahilsahilsa herring ("āχāϞāĻŋāĻļin Bengali) or hilsa shad) is a species of fish related to the herring, in the Clupeidae family. It is a very popular and sought-after food fish in the Subcontinent . It is national fish of Bangladesh. The fish contributes about 12% of the total fish production and about 1.15% of GDP of this country.   Sixty-five percent of total produced ilish in the world is produced in Bangladesh which applied for Geographical Indication (GI) in 2004, About 450,000 people are directly involved in the catching of the fish as a large part of their livelihood; around four to five million people are indirectly involved with the trade.

In Bangladesh, fish are caught in the Meghna-Jamuna river  which flows into the Bay of Bengal. In every year Bay of Bengal region of Bangladesh , the fisherman caught huge number of Hilsa fish.

See  Plethora of Hilsha fish click the link below.

https://www.youtube.com/watch?v=CZ-4dpgdVDc&t=122s